UNC Hospitals preps for triple-tandem stem cell transplantNBC17.comA Carrboro man will get the first triple-tandem stem cell transplant done at UNC Hospitals to treat testicular cancer. (more) A Carrboro man is getting the first triple-tandem stem cell…
Noteworthy Research Spans Range of Malignancies – OncLive
OncLiveNoteworthy Research Spans Range of MalignanciesOncLiveRituximab antibodies (turquoise) bind to the CD20 cell-surface markers on B-cells. A second paper reported the results of a most interesting phase III randomized trial that the Eastern Cooper…
Mother honours Anthony Kelly's organ donation wishes – BBC News
BBC NewsMother honours Anthony Kelly's organ donation wishesBBC NewsA mother says she has honoured her son's wishes and donated his organs to other people following his death after a road collision in Denbighshire. Minibus passenger Anthony Kel…
Transplants Using Stem Cells From The Blood Or Bone Marrow Yield Similar … – The MDS Beacon
Transplants Using Stem Cells From The Blood Or Bone Marrow Yield Similar …The MDS BeaconFor blood cancer patients receiving a stem cell transplant from an unrelated donor, survival rates appear to be similar regardless of whether the stem cells were …
Oral cyclosporine observed most effective in infection-driven atopic dermatitis – Pediatric SuperSite
Oral cyclosporine observed most effective in infection-driven atopic dermatitisPediatric SuperSiteTo determine how effective oral cyclosporine would be in children for the treatment of atopic dermatitis (AD) unresponsive to topical corticosteroids and …
Fresenius Medical Care AG & Co. KGaA; Analysis of Agreement Containing Consent … – Insurance News Net (press release)
Fresenius Medical Care AG & Co. KGaA; Analysis of Agreement Containing Consent …Insurance News Net (press release)Kidney transplantation is the only alternative to dialysis for ESRD patients. However, the wait-time for donor kidneys–during which…
IMARC Group Releases the Most Comprehensive Study on the US Follow-on … – PharmiWeb.com (press release)
IMARC Group Releases the Most Comprehensive Study on the US Follow-on …PharmiWeb.com (press release)… Interferon Beta-1A (Rebif), Interferon Beta-1B (Betaferon), Bevacizumab (Avastin), Trastuzumab (Herceptin), Rituximab (Mabthera/Rituxan), Cetuxima…
Rigel Announces Fourth Quarter and Year End 2011 Financial Results – MarketWatch (press release)
Rigel Announces Fourth Quarter and Year End 2011 Financial ResultsMarketWatch (press release)In the fourth quarter of 2011, Rigel initiated Phase 1 clinical studies of R548 with a focus on its potential to treat transplant rejection and other immune sy…
Heart failure drug gets initial go-ahead – Nursing Times
Heart failure drug gets initial go-aheadNursing TimesA drug that can reduce the need for heart failure patients to be hospitalised by 30% has been given the green light by European regulators. You now need to register for FREE to read our news. Please …
Indian CMO will make Roche blockbusters – InPharm
InPharmIndian CMO will make Roche blockbustersInPharmMeanwhile, a separate report in the Economic Times has suggested that the deal could also be extended to cover Roche's non-Hodgkin's lymphoma therapy MabThera/Rituxan (rituximab). The deal is…